Detalhe da pesquisa
1.
Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator.
Support Care Cancer
; 32(1): 69, 2023 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157081
2.
Efficacy and safety of twice-daily tramadol hydrochloride bilayer sustained-release tablets with an immediate release component for postherpetic neuralgia: Results of a Phase III, randomized, double-blind, placebo-controlled, treatment-withdrawal study.
Pain Pract
; 23(3): 277-289, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478501
3.
Efficacy and Safety of Tramadol Hydrochloride Twice-Daily Sustained-Release Bilayer Tablets with an Immediate-Release Component for Chronic Pain Associated with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study.
Clin Drug Investig
; 42(5): 403-416, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35435639